Literature DB >> 10580502

Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function.

M M Reddy1, M J Light, P M Quinton.   

Abstract

It is increasingly being recognized that cells coordinate the activity of separate ion channels that allow electrolytes into the cell. However, a perplexing problem in channel regulation has arisen in the fatal genetic disease cystic fibrosis, which results from the loss of a specific Cl- channel (the CFTR channel) in epithelial cell membranes. Although this defect clearly inhibits the absorption of Na+ in sweat glands, it is widely accepted that Na+ absorption is abnormally elevated in defective airways in cystic fibrosis. The only frequently cited explanation for this hypertransport is that the activity of an epithelial Na+ channel (ENaC) is inversely related to the activity of the CFTR Cl- channel. However, we report here that, in freshly isolated normal sweat ducts, ENaC activity is dependent on, and increases with, CFTR activity. Surprisingly, we also find that the primary defect in Cl- permeability in cystic fibrosis is accompanied secondarily by a Na+ conductance in this tissue that cannot be activated. Thus, reduced salt absorption in cystic fibrosis is due not only to poor Cl- conductance but also to poor Na+ conductance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580502     DOI: 10.1038/46297

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  65 in total

1.  Vacuolar-type H+ -ATPase distribution in unstimulated and acetylcholine-activated isolated human eccrine sweat glands.

Authors:  D L Bovell; M T Clunes; E Roussa; J Burry; H Y Elder
Journal:  Histochem J       Date:  2000-07

Review 2.  Regulation of the epithelial sodium channel by accessory proteins.

Authors:  Kelly Gormley; Yanbin Dong; Giuseppe A Sagnella
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 3.  Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion.

Authors:  Min Goo Lee; Ehud Ohana; Hyun Woo Park; Dongki Yang; Shmuel Muallem
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 4.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

5.  Altered ion transport by thyroid epithelia from CFTR(-/-) pigs suggests mechanisms for hypothyroidism in cystic fibrosis.

Authors:  Hui Li; Suhasini Ganta; Peying Fong
Journal:  Exp Physiol       Date:  2010-08-20       Impact factor: 2.969

6.  Autosomal recessive hyponatremia due to isolated salt wasting in sweat associated with a mutation in the active site of Carbonic Anhydrase 12.

Authors:  Emad Muhammad; Neta Leventhal; Galit Parvari; Aaron Hanukoglu; Israel Hanukoglu; Vered Chalifa-Caspi; Yael Feinstein; Jenny Weinbrand; Harel Jacoby; Esther Manor; Tal Nagar; John C Beck; Val C Sheffield; Eli Hershkovitz; Ruti Parvari
Journal:  Hum Genet       Date:  2010-12-24       Impact factor: 4.132

Review 7.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes.

Authors:  G Nagel; P Barbry; H Chabot; E Brochiero; K Hartung; R Grygorczyk
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

9.  The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl- concentration.

Authors:  J König; R Schreiber; T Voelcker; M Mall; K Kunzelmann
Journal:  EMBO Rep       Date:  2001-10-17       Impact factor: 8.807

10.  Endolymphatic sodium homeostasis by extramacular epithelium of the saccule.

Authors:  Sung Huhn Kim; Daniel C Marcus
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.